Condition
Diabetic Peripheral Neuropathic Pain clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Diabetic Peripheral Neuropathic Pain clinical trials that are recruiting, at sites in 8 countries (most in United States (5), Canada (1), France (1)). By phase: Phase 3 (2), Phase 2 (2), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 8Countries
Newest Diabetic Peripheral Neuropathic Pain clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HRS-2129 for diabetic peripheral neuropathic pain | Phase 1 | Beijing, Beijing Municipality and 1 other locations | Recruiting | Jan 30, 2026 |
| LY4065967 for diabetic peripheral neuropathic pain (part of a chronic pain master protocol) | Phase 2 | Birmingham, Alabama and 35 other locations | Recruiting | Dec 16, 2025 |
| Suzetrigine for pain from diabetic peripheral neuropathy | Phase 3 | Birmingham, Alabama and 74 other locations | Recruiting | Nov 17, 2025 |
| Evaluating Suzetrigine for Pain from Diabetic Peripheral Neuropathy | Phase 3 | Anniston, Alabama and 75 other locations | Recruiting | Oct 8, 2024 |
| Evaluating VX-993 for pain from diabetic nerve damage | Phase 2 | Cullman, Alabama and 46 other locations | Recruiting | Oct 1, 2024 |
| Assessing a new spray treatment for diabetic nerve pain | Phase 1 | Fredericksburg, Texas | Recruiting | Apr 11, 2024 |
All recruiting trials (6)
-
HRS-2129 for diabetic peripheral neuropathic pain
This trial will test whether HRS-2129 tablets reduce pain in adults with diabetic peripheral neuropathy compared with placebo.
-
LY4065967 for diabetic peripheral neuropathic pain (part of a chronic pain master protocol)
This trial tests whether LY4065967 can safely reduce pain in adults with diabetic peripheral neuropathic pain.
-
Suzetrigine for pain from diabetic peripheral neuropathy
This trial will test whether Suzetrigine reduces pain in adults with diabetic peripheral neuropathy.
-
Evaluating Suzetrigine for Pain from Diabetic Peripheral Neuropathy
This study is testing if a new medication called Suzetrigine can help people with diabetic nerve pain feel better compared to a placebo and a standard treatment.
-
Evaluating VX-993 for pain from diabetic nerve damage
This study is testing if a new medication called VX-993 can help people with diabetes who have been dealing with pain in their legs and feet from nerve damage feel better compared to a standard treatment and a placebo.
-
Assessing a new spray treatment for diabetic nerve pain
This study is testing a new spray treatment for diabetic nerve pain to see if it helps relieve pain and is safe for patients to use.
Quick answers
How many Diabetic Peripheral Neuropathic Pain clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (5 trials), Canada (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.